(TSLA) Tesla - Ratings and Ratios
Electric Vehicles, Energy Storage, Solar Panels, Superchargers
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 52.3% |
| Value at Risk 5%th | 80.2% |
| Relative Tail Risk | -6.79% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.48 |
| Alpha | -11.64 |
| CAGR/Max DD | 0.79 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.378 |
| Beta | 2.274 |
| Beta Downside | 2.090 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.77% |
| Mean DD | 22.12% |
| Median DD | 20.54% |
Description: TSLA Tesla December 02, 2025
Tesla, Inc. (NASDAQ:TSLA) designs, manufactures, leases, and sells electric vehicles (EVs) and energy-generation/storage systems across the United States, China, and other international markets. The company reports two operating segments: Automotive, which includes vehicle sales (new and used), after-sales services, Supercharger access, insurance, and the sale of regulatory credits; and Energy Generation & Storage, which covers solar panels, Powerwall/Powerpack installations, and related financing and service offerings.
Key recent metrics illustrate the firm’s growth trajectory and emerging risks: Q4 2023 vehicle deliveries reached ~405,000 units, while automotive gross margin held near 21% despite higher commodity prices; regulatory-credit revenue fell 38% YoY, signaling increasing reliance on pure-car sales. On the energy side, solar-plus-storage installations grew 22% YoY, but the segment still contributes <10% of total revenue, making it a secondary growth lever. Macro-level drivers include accelerating EV adoption rates (global EV stock surpassed 15 million in 2023), tightening emissions standards, and the impact of rising interest rates on consumer financing.
For a deeper, data-driven assessment of Tesla’s valuation dynamics, you may find ValueRay’s analytical dashboards worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (5.31b TTM) > 0 and > 6% of Revenue (6% = 5.74b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 2.10pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 34.89% (prev 26.56%; Δ 8.33pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 15.75b > Net Income 5.31b (YES >=105%, WARN >=100%) |
| Net Debt (-5.09b) to EBITDA (13.21b) ratio: -0.39 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.07 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (3.53b) change vs 12m ago 0.83% (target <= -2.0% for YES) |
| Gross Margin 17.01% (prev 18.23%; Δ -1.22pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 75.42% (prev 81.06%; Δ -5.63pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 20.66 (EBITDA TTM 13.21b / Interest Expense TTM 349.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.71
| (A) 0.25 = (Total Current Assets 64.65b - Total Current Liabilities 31.29b) / Total Assets 133.74b |
| (B) 0.29 = Retained Earnings (Balance) 38.16b / Total Assets 133.74b |
| (C) 0.06 = EBIT TTM 7.21b / Avg Total Assets 126.79b |
| (D) 0.72 = Book Value of Equity 38.37b / Total Liabilities 53.02b |
| Total Rating: 3.71 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 48.23
| 1. Piotroski 5.0pt |
| 2. FCF Yield 0.45% |
| 3. FCF Margin 7.15% |
| 4. Debt/Equity 0.17 |
| 5. Debt/Ebitda -0.39 |
| 6. ROIC - WACC (= -8.16)% |
| 7. RoE 6.97% |
| 8. Rev. Trend 60.05% |
| 9. EPS Trend -73.18% |
What is the price of TSLA shares?
Over the past week, the price has changed by +1.05%, over one month by +1.40%, over three months by +29.81% and over the past year by +12.58%.
Is TSLA a buy, sell or hold?
- Strong Buy: 14
- Buy: 7
- Hold: 16
- Sell: 3
- Strong Sell: 7
What are the forecasts/targets for the TSLA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 392.9 | -13% |
| Analysts Target Price | 392.9 | -13% |
| ValueRay Target Price | 491.6 | 8.9% |
TSLA Fundamental Data Overview December 06, 2025
P/E Trailing = 317.8532
P/E Forward = 192.3077
P/S = 15.8071
P/B = 17.8514
P/EG = 8.5739
Beta = 1.872
Revenue TTM = 95.63b USD
EBIT TTM = 7.21b USD
EBITDA TTM = 13.21b USD
Long Term Debt = 5.61b USD (from longTermDebt, last quarter)
Short Term Debt = 2.85b USD (from shortTermDebt, last quarter)
Debt = 13.79b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -5.09b USD (from netDebt column, last quarter)
Enterprise Value = 1524.30b USD (1511.68b + Debt 13.79b - CCE 1.17b)
Interest Coverage Ratio = 20.66 (Ebit TTM 7.21b / Interest Expense TTM 349.0m)
FCF Yield = 0.45% (FCF TTM 6.83b / Enterprise Value 1524.30b)
FCF Margin = 7.15% (FCF TTM 6.83b / Revenue TTM 95.63b)
Net Margin = 5.55% (Net Income TTM 5.31b / Revenue TTM 95.63b)
Gross Margin = 17.01% ((Revenue TTM 95.63b - Cost of Revenue TTM 79.37b) / Revenue TTM)
Gross Margin QoQ = 17.99% (prev 17.24%)
Tobins Q-Ratio = 11.40 (Enterprise Value 1524.30b / Total Assets 133.74b)
Interest Expense / Debt = 0.55% (Interest Expense 76.0m / Debt 13.79b)
Taxrate = 29.10% (570.0m / 1.96b)
NOPAT = 5.11b (EBIT 7.21b * (1 - 29.10%))
Current Ratio = 2.07 (Total Current Assets 64.65b / Total Current Liabilities 31.29b)
Debt / Equity = 0.17 (Debt 13.79b / totalStockholderEquity, last quarter 79.97b)
Debt / EBITDA = -0.39 (Net Debt -5.09b / EBITDA 13.21b)
Debt / FCF = -0.74 (Net Debt -5.09b / FCF TTM 6.83b)
Total Stockholder Equity = 76.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.97% (Net Income 5.31b / Total Assets 133.74b)
RoE = 6.97% (Net Income TTM 5.31b / Total Stockholder Equity 76.21b)
RoCE = 8.81% (EBIT 7.21b / Capital Employed (Equity 76.21b + L.T.Debt 5.61b))
RoIC = 6.12% (NOPAT 5.11b / Invested Capital 83.60b)
WACC = 14.27% (E(1511.68b)/V(1525.47b) * Re(14.40%) + D(13.79b)/V(1525.47b) * Rd(0.55%) * (1-Tc(0.29)))
Discount Rate = 14.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.49%
[DCF Debug] Terminal Value 55.74% ; FCFE base≈5.54b ; Y1≈4.93b ; Y5≈4.12b
Fair Price DCF = 10.26 (DCF Value 34.11b / Shares Outstanding 3.33b; 5y FCF grow -13.76% → 3.0% )
EPS Correlation: -73.18 | EPS CAGR: -18.76% | SUE: -0.51 | # QB: 0
Revenue Correlation: 60.05 | Revenue CAGR: 13.08% | SUE: 1.32 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.45 | Chg30d=-0.002 | Revisions Net=-3 | Analysts=11
EPS next Year (2026-12-31): EPS=2.27 | Chg30d=+0.016 | Revisions Net=-11 | Growth EPS=+37.9% | Growth Revenue=+14.9%
Additional Sources for TSLA Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle